Technical Analysis for IDNA - iShares Genomics Immunology and Healthcare ETF

Grade Last Price % Change Price Change
D 43.7 -0.21% -0.09
IDNA closed down 2.1 percent on Wednesday, May 12, 2021, on 76 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical IDNA trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish -0.21%
180 Bearish Setup Bearish Swing Setup -0.21%
NR7 Range Contraction -0.21%
Inside Day Range Contraction -0.21%
200 DMA Support Bullish -2.30%
Lower Bollinger Band Touch Weakness -2.30%
Oversold Stochastic Weakness -1.40%
50 DMA Resistance Bearish -4.04%
Gapped Up Strength -4.04%
Oversold Stochastic Weakness -4.04%
Older End-of-Day Signals for IDNA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 2 minutes ago
Bearish 180 Entry 2 minutes ago
Fell Below Previous Day's Low 2 minutes ago
200 DMA Support about 2 hours ago
200 DMA Resistance about 2 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Classification

Keywords: Exchange Traded Fund Immunology Genomics Factset

Top 10 Components

Symbol Grade Price % Change Allocation
BNTX B -2.22 5.77
BGNE C -0.41 5.59
EXEL A 0.70 5.18
FATE D -0.76 5.07
GILD A 1.30 4.45
MRNA B -0.31 4.33
REGN B 1.63 4.06
BPMC F 0.64 3.64
TAK D 0.00 3.62
CRSP F -0.44 3.19
View All IDNA Holdings

Is IDNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 55.03
52 Week Low 33.84
Average Volume 77,548
200-Day Moving Average 44.11
50-Day Moving Average 45.78
20-Day Moving Average 46.29
10-Day Moving Average 45.66
Average True Range 1.41
ADX 17.7
+DI 20.09
-DI 34.66
Chandelier Exit (Long, 3 ATRs ) 44.73
Chandelier Exit (Short, 3 ATRs ) 46.74
Upper Bollinger Band 49.28
Lower Bollinger Band 43.30
Percent B (%b) 0.08
BandWidth 12.91
MACD Line -0.46
MACD Signal Line -0.10
MACD Histogram -0.3541
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.94
Resistance 3 (R3) 45.05 44.79 44.75
Resistance 2 (R2) 44.79 44.50 44.73 44.68
Resistance 1 (R1) 44.29 44.32 44.16 44.17 44.62
Pivot Point 44.02 44.02 43.96 43.97 44.02
Support 1 (S1) 43.53 43.73 43.39 43.41 42.96
Support 2 (S2) 43.26 43.55 43.20 42.90
Support 3 (S3) 42.76 43.26 42.83
Support 4 (S4) 42.64